Below are the most recent publications written about "SEER Program" by people in Profiles.
-
El Khoury CJ, Freedland SJ, Gandhi K, Keith SW, Nikita N, Shaver A, Sharma S, Kelly WMK, Lu-Yao G. Disparities in the utilization of magnetic resonance imaging for prostate cancer detection: a population-based study. J Natl Cancer Inst. 2025 Feb 01; 117(2):270-278.
-
Leslie Salewon M, Pathak R, Dooley WC, Squires RA, Rui H, Chervoneva I, Tanaka T. Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare. Breast Cancer Res. 2024 Dec 30; 26(1):191.
-
Torres-Small S, Davies C, Kumsa FA, Maroda A, Shaban-Nejad A, Gleysteen JP, Schwartz DL, Wood CB. Effects of Rurality, Socioeconomic Status, and Race on Head and Neck Squamous Cell Carcinoma Outcomes. Laryngoscope. 2025 May; 135(5):1715-1723.
-
Peleman J, Ruan M, Dey T, Chiang S, Dilger A, Mitchell MB, Jung YS, Ramanathan M, Mady L, Yu S, Cramer J, Lee SE. Air pollution exposure and head and neck cancer incidence. Sci Rep. 2024 11 12; 14(1):26998.
-
Kim HJ, Griffith KA, Ricciardi R, Le D, Glenn A, Cameron V, Juon HS. Exploring disparities in healthcare utilization, cancer care experience, and beliefs about cancer among asian and hispanic cancer survivors. Support Care Cancer. 2024 Oct 30; 32(11):756.
-
William Stout R, Gallo N, Torres-Small S, Okose O, Zhao C, Hayes T, Gleysteen J, Wood CB. The Role of Socioeconomic Status in Patients With Cutaneous Melanoma of the Head and Neck. Laryngoscope. 2025 01; 135(1):153-160.
-
Bakaloudi DR, Koehne EL, Diamantopoulos LN, Holt SK, Sekar RR, Ghali F, Vakar-Lopez F, Nyame YA, Psutka SP, Gore JL, de la Calle CM, Lin DW, Schade GR, Liao JJ, Hsieh AC, Yezefski T, Hawley JE, Yu EY, Montgomery RB, Grivas P, Wright JL. Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study. Clin Genitourin Cancer. 2024 Dec; 22(6):102208.
-
DuBois TD, Henry KA, Siegel SD, Lynch SM. Geographic Disparities in Cancer Incidence in the US Population Aged 20 to 49 Years, 2016-2020. Prev Chronic Dis. 2024 May 09; 21:E32.
-
Nikita N, Gandhi K, Keith SW, Sharma S, Kelly WK, Lu-Yao G. The rates of septicemia in older adults with prostate cancer treated with abiraterone or enzalutamide: A population-based study. J Geriatr Oncol. 2024 06; 15(5):101773.
-
Karsh L, Du S, He J, Waters D, Muser E, Shore N. Differences in real-world outcomes by risk classification for localized prostate cancer patients after radiation therapy. Prostate. 2024 Aug; 84(11):1047-1055.